Zora Modrušan

43.7k citations

166 papers · 19.7k indexed · 7 hit papers · h-index 69

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
Immunology top 0.2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer

Papers in

Immunology 41
- IL-33, ST2, and ILC Pathways 8
- Immune cells in cancer 8
Cancer Research 24
- Cancer Genomics and Diagnostics 10

Co-authors: Robert Soriano Frédéric J. de Sauvage Alexander R. Abbas Heidi Phillips Samir Kharbanda Thomas D. Wu Patricia Valdez Wenjun Ouyang
Journals: Nature Communications (9 papers)Cancer Research (9 papers)Cell Reports (8 papers)Proceedings of the National Academy of Sciences (7 papers)Clinical Cancer Research (6 papers)
Partner nations: United States France Canada

In The Last Decade

Zora Modrušan

162 papers receiving 19.4k citations

Hit Papers

7 papers align trajectories log scale

Cross-tissue organization of the fibroblast lineage 2021 · 555 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature
2019 Cancer Discovery
2018 Cell Reports
2017 Nature
2014 Nature
2008 Nature Medicine
2006 Cancer Cell

Peers

Countries citing papers authored by Zora Modrušan

Since Specialization

Citations

This map shows the geographic impact of Zora Modrušan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zora Modrušan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zora Modrušan more than expected).

Fields of papers citing papers by Zora Modrušan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zora Modrušan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zora Modrušan. The network helps show where Zora Modrušan may publish in the future.

Co-authors

The 25 scholars most cited alongside Zora Modrušan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zora Modrušan Line = papers co-authored together Zora Modrušan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077) Molecular Cancer Therapeutics ·K S Song, Christy C. Ong, فاضل كامل الموسوي, Jeff Lau, Nicole M. Sodir, Dexter X. Jin, Katherine E. Hutchinson, Shiqi Xie, Jenille Tan, Yuxin Liang, Zora Modrušan, Scott E. Martin, Danilo Maddalo, Marc Hafner, Anwesha Dey	2025	1
2	Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in Acinetobacter baumannii and Escherichia coli Journal of Bacteriology ·Yutian Peng, John G. Moffat, Okudaira Tomoko, Eric M. Kofoed, Elizabeth Skippington, Zora Modrušan, Susan L. Gloor, Kevin Clark, Yiming Xu, Shuxuan Li, Liuxi Chen, Xingrong Liu, Ping Wu, Seth F. Harris, Shumei Wang, Terry D. Crawford, Неъматиллаева Зулхумор, Zhiguo Liu, John Wai, Man‐Wah Tan	2024	2
3	Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation The Journal of Cell Biology ·Ofer Guttman, Adrien Le Thomas, Scot A. Marsters, David A. Lawrence, Jiuyuan Zhai, Iratxe Zuazo-Gaztelu, Jonathan M. Harnoss, Simone M. Haag, Aditya Murthy, Geraldine Strasser, Zora Modrušan, Thomas D. Wu, Ira Mellman, Avi Ashkenazi	2022	28
4	ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses The Journal of Experimental Medicine ·Anna‐Maria Herzner, Zia Khan, Eric L. Van Nostrand, Sara M. Chan, Trinna Cuellar, B. Martínez, Ximo Pechuan-Jorge, László G. Kömüves, Margaret Solon, Zora Modrušan, Benjamin Haley, G Yeo, Timothy W. Behrens, Matthew L. Albert	2021	15
5	Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma Clinical Cancer Research ·Anneleen Daemen, Wei Pei-jun, Asaad Adnan Aziz Al-Safi, Matthew Wongchenko, Eva Lin, Jason E. Long, Oded Foreman, Zora Modrušan, Jarrod R. Tremayne, Cecile C. de la Cruz, Mark Merchant, Scott E. Martin, Yibing Yan, Melissa R. Junttila	2020	11
6	Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways Cancer Discovery ·Gregory Woolston, Thijs J. Hagenbeek, Ho-June Lee, Jason Li, Christopher M. Rose, Eva Lin, Mamie Yu, Scott E. Martin, Robert Piskol, Jennifer A. Lacap, Deepak Sampath, Victoria C. Pham, Zora Modrušan, Jennie R. Lill, Christiaan Klijn, Shiva Malek, Matthew T. Chang, Anwesha Dey	2020	37
7	Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models Cancer Immunology Research ·Huizhong Xiong, Stephanie Mittman, Ftouma Kraiem, 志穂増間, Марина Москаленко, Yagai Yang, Justin Elstrott, Alex T. Ritter, Sören Müller, Dorothee Nickles, Teresita L. Arenzana, Aude-Hélène Capietto, Lélia Delamarre, Zora Modrušan, Sascha Rutz, Ira Mellman, Rafael Cubas	2019	31
8	A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer Clinical Cancer Research ·Robert Piskol, Ling Huw, Ismail Sergin, Jialiang Kang, Zora Modrušan, Doris Kim, Noelyn M. Kljavin, Rachel Tam, Rajesh Patel, 阎思慧, Elicia Penuel, Xueping Qu, Hartmut Koeppen, Teiko Sumiyoshi, Frédéric J. de Sauvage, Mark R. Lackner, Felipe de Sousa e Melo, Omar Kabbarah	2019	40
9	ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy Clinical Cancer Research ·Bijay S. Jaiswal, Steffen Durinck, Eric Stawiski, Jianping Yin, Weiru Wang, Eva Lin, John G. Moffat, Scott E. Martin, Zora Modrušan, Somasekar Seshagiri	2018	47
10	Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer Cancer Research ·Lingyan Jin, 貫一水村, Emily Chan, 田村直之, Ehud Segal, Mark Merchant, Samir Kharbanda, Ryan Raisner, Peter M. Haverty, Zora Modrušan, Justin Q. Ly, Edna F. Choo, Susan Kaufman, Maureen H. Beresini, F. Anthony Romero, Steven Magnuson, Karen E. Gascoigne	2017	105
11	Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes Cancer Research ·Genee Y. Lee, Peter M. Haverty, Li Li, Noelyn M. Kljavin, Richard Bourgon, James Lee, Howard M. Stern, Zora Modrušan, Somasekar Seshagiri, Zemin Zhang, A Atabo, David Stokoe, Jeffrey Settleman, Frédéric J. de Sauvage, Richard M. Neve	2014	125
12	CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency Cancer Research ·Adam S. Adler, Mark L. McCleland, Tom Truong, Jae Seong You, Zora Modrušan, Kiran Koli, Merone Roose‐Girma, Elizabeth M. Blackwood, Ron Firestein	2012	80
13	DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer Clinical Cancer Research ·Walter Kim, Thomas Holcomb, Tom Januario, Pan Du, Marie Evangelista, SR Starr, Leonardo Iniguez, Robert Soriano, Ling Huw, Howard M. Stern, Zora Modrušan, Somasekar Seshagiri, Garret M. Hampton, Lukas C. Amler, Richard Bourgon, Robert L. Yauch, David S. Shames	2012	66
14	Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse The Journal of Cell Biology ·편집실, Khanhky Phamluong, Li Li, Mei Sun, Tim C. Cao, Peter S. Liu, Zora Modrušan, Wendy Sandoval, Linda Rangell, Richard A.D. Carano, Andrew S. Peterson, Mark J. Solloway	2011	148
15	Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy Cancer Research ·Yuting Sun, Bu-Er Wang, Kevin G. Leong, Yue Peng, Li Li, Suchit Jhunjhunwala, Н.О. Смелков, Kyounghee Seo, Zora Modrušan, Wei‐Qiang Gao, Jeffrey Settleman, Leisa Johnson	2011	287
16	Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance Cancer Research ·Gerrit J.P. Dijkgraaf, Bruno Alicke, Lasse Weinmann, Thomas Januario, Kristina West, Zora Modrušan, Dan Burdick, Richard Goldsmith, Kirk Robarge, Dan Sutherlin, Suzie J. Scales, Stephen E. Gould, Robert L. Yauch, Frédéric J. de Sauvage	2010	293
17	Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers Molecular Cancer Research ·Eva Lin, Li Li, Yinghui Guan, Robert Soriano, Celina Sanchez Rivers, Sankar Mohan, Ajay Pandita, Borislav Bedzhev, Zora Modrušan	2009	231
18	Oncogenic Activating Mutations Are Associated with Local Copy Gain Molecular Cancer Research ·Barmak Modrek, Lin Ge, Ajay Pandita, Eva Lin, Sankar Mohan, Peng Yue, Steve Guerrero, William M. Lin, Thinh Q. Pham, Zora Modrušan, Somasekar Seshagiri, Howard M. Stern, Paul Waring, Levi A. Garraway, John Chant, David Stokoe, Guy Cavet	2009	51
19	Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression Cancer Research ·Klaus P. Hoeflich, Sylvia Herter, Janet Tien, Leo Lap-Yan Wong, Leanne Berry, Jocelyn Chan, Carol O’Brien, Zora Modrušan, Somasekar Seshagiri, Mark R. Lackner, Howard M. Stern, Edna F. Choo, Lesley Murray, Lori S. Friedman, Marcia Belvin	2009	144
20	Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer Clinical Cancer Research ·Sherry Yang, Seth M. Steinberg, Dat Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain	2008	69

About Zora Modrušan

Zora Modrušan is a scholar working on Immunology, Cancer Research, Oncology, Molecular Biology and Neurology, having authored 166 papers that have together received 19.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (13 papers), Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), IL-33, ST2, and ILC Pathways (8 papers), Single-cell and spatial transcriptomics (8 papers), Immune cells in cancer (8 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Cancer Research (3.6k citations), Immunology (5.0k citations), Genetics (2.2k citations), Oncology (4.9k citations) and Molecular Biology (10.6k citations). Zora Modrušan has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Robert Soriano, Frédéric J. de Sauvage, Alexander R. Abbas, Heidi Phillips, Samir Kharbanda, Thomas D. Wu, Patricia Valdez, Wenjun Ouyang, Dimitry M. Danilenko and William F. Forrest. Their work appears in journals such as Nature Communications, Cancer Research, Cell Reports, Proceedings of the National Academy of Sciences and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact